US FDA said Aug. 22 it wants to hold a public meeting in October on an initiative to streamline the electronic submission of chemistry, manufacturing and controls information in new drug applications using standardized data elements the agency is developing.
The Oct
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?